2001
DOI: 10.1097/00003086-200105000-00014
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Osteonecrosis in the Hip of Pediatric Patients by Free Vascularized Fibular Graft

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
30
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 43 publications
(30 citation statements)
references
References 17 publications
0
30
0
Order By: Relevance
“…Although we do not have long-term outcomes ([ 10 years postoperatively) to report on, approximately 90% of patients undergoing FVFG for AVN after SCFE have retained their native hip at an average of 8.4 years. In other pediatric conditions, we have reported a survival rate approaching 85% at 4 years [3].…”
Section: Resultsmentioning
confidence: 84%
See 2 more Smart Citations
“…Although we do not have long-term outcomes ([ 10 years postoperatively) to report on, approximately 90% of patients undergoing FVFG for AVN after SCFE have retained their native hip at an average of 8.4 years. In other pediatric conditions, we have reported a survival rate approaching 85% at 4 years [3].…”
Section: Resultsmentioning
confidence: 84%
“…FVFG has reported rates of overall survivorship in the range of 61-96% [2][3][4][15][16][17]. In another study recently performed at our institution looking at 65 hips undergoing FVFG for multiple etiologies contributing to osteonecrosis of the femoral head, 40% of patients went on to THA at an average of 8.3 years after undergoing FVFG [4].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite including children who were younger than 7 years old [10,11,18,25,26] in five studies using four of the six PROs found (mHHS, HHS, Iowa, Merle d'Aubigné), the papers reviewed indicated no issues in the administration of these adult PROs (Table 2). Several papers directly compared results from a PRO administered to pediatric patients with results from adult studies using the same PRO [5,10,16,23,26]. It is clear that a hip-specific PRO validated for pediatric patients in a range of conditions, including impingement, is needed to fill a gap in the range of outcome measures available to clinicians and researchers.…”
Section: Discussionmentioning
confidence: 99%
“…The advantage of FVFG lies in the combination of femoral head decompression, removal of necrotic lesion, introduction of osteoinductive cancellous bone, and vascularised cortical bone support of the subchondral surface [24]. There are multiple reports on the successful mid-and long-term outcomes of FVFG [7][8][9].…”
Section: Discussionmentioning
confidence: 99%